Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.

Nair S, Phillips AO, Norton N, Spurlock G, Williams HJ, Craig KJ, Williams JD, Williams NM, Bowen T.

J Nephrol. 2008 May-Jun;21(3):400-5.

PMID:
18587729
2.

Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.

Hirakawa S, Lange EM, Colicigno CJ, Freedman BI, Rich SS, Bowden DW.

Am J Kidney Dis. 2003 Jul;42(1):133-42.

PMID:
12830465
3.

Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus.

Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A.

Diabet Med. 2001 Nov;18(11):906-14.

PMID:
11703436
5.

Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.

Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, Rai TS, Sud K, Singal PK.

PLoS One. 2009;4(4):e5168. doi: 10.1371/journal.pone.0005168. Epub 2009 Apr 9.

6.

Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2003 Aug;14(8):2015-24.

7.

Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy.

Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y, Kanauchi M.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S182-5.

PMID:
11576951
9.

A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.

Zhang D, Ma J, Brismar K, Efendic S, Gu HF.

J Diabetes Complications. 2009 Jul-Aug;23(4):265-72. doi: 10.1016/j.jdiacomp.2008.05.004. Epub 2008 Jul 3.

PMID:
18599322
10.

Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes.

Ng DP, Nurbaya S, Choo S, Koh D, Chia KS, Krolewski AS.

Nephrol Dial Transplant. 2008 Jul;23(7):2260-4. doi: 10.1093/ndt/gfm946. Epub 2008 Feb 10.

PMID:
18263927
11.

Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals.

Lim SC, Liu JJ, Low HQ, Morgenthaler NG, Li Y, Yeoh LY, Wu YS, Goh SK, Chionh CY, Tan SH, Kon YC, Soon PC, Bee YM, Subramaniam T, Sum CF, Chia KS.

Diabetologia. 2009 Jul;52(7):1343-51. doi: 10.1007/s00125-009-1368-x. Epub 2009 May 5.

PMID:
19415232
12.

The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.

Patel A, Scott WR, Lympany PA, Rippin JD, Gill GV, Barnett AH, Bain SC; Warren 3/UK GoKind Study Group.

Diabet Med. 2005 Jan;22(1):69-73.

PMID:
15606694
13.

Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy.

McKnight AJ, Savage DA, Patterson CC, Brady HR, Maxwell AP.

J Hum Genet. 2006;51(4):383-6. Epub 2006 Feb 24.

PMID:
16501850
14.

Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes.

Nosratabadi R, Arababadi MK, Salehabad VA, Shamsizadeh A, Mahmoodi M, Sayadi AR, Kennedy D.

Int J Immunogenet. 2010 Dec;37(6):493-7. doi: 10.1111/j.1744-313X.2010.00953.x. Epub 2010 Aug 19.

PMID:
20727043
15.

Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus.

McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP; Warren 3/UK GoKinD Study Group.

Diabetologia. 2009 May;52(5):844-9. doi: 10.1007/s00125-009-1281-3. Epub 2009 Feb 27.

PMID:
19247629
16.

The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers.

Monslow J, Williams JD, Norton N, Guy CA, Price IK, Coleman SL, Williams NM, Buckland PR, Spicer AP, Topley N, Davies M, Bowen T.

Int J Biochem Cell Biol. 2003 Aug;35(8):1272-83.

PMID:
12757764
17.

Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.

Guan J, Zhao HL, Baum L, Sui Y, He L, Wong H, Lai FM, Tong PC, Chan JC.

Nephrol Dial Transplant. 2009 Jun;24(6):1889-95. doi: 10.1093/ndt/gfn734. Epub 2009 Feb 14.

PMID:
19218599
18.

Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetes.

Conway BR, Maxwell AP, Savage DA, Patterson CC, Doran PP, Murphy M, Brady HR, Fogarty DG.

Diabetes. 2004 Apr;53(4):1162-5.

19.
20.

The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.

Eroglu Z, Erdogan M, Tetik A, Karadeniz M, Cetinalp S, Kosova B, Gunduz C, Ozgen AG, Yilmaz C.

Diabetes Metab Res Rev. 2007 Nov;23(8):621-4.

PMID:
17354258

Supplemental Content

Support Center